Global Varicose veins treatment Market
Global Varicose veins treatment Market

Varicose veins treatment Comprehensive Study by Treatment (Surgery, Ligation and Stripping, Sclerotherapy, Radiofrequency Ablation, Endovenous Laser Treatment, Transilluminated Powered Phlebectomy), Disease (Greater Saphenous Varicose Vein, Small Saphenous Varicose Vein, Others), Product (Laser & RF Ablation, Venous Closure, Surgical), Diagnosis (Doppler Test, Color Duplex Ultrasound Scan), End User (Hospitals, Clinics, Ambulatory Surgical Centers) Players and Region - Global Market Outlook to 2025

Varicose veins treatment Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Oct 2020 Edition 248 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Varicose veins treatment Market?

The varicose veins treatment market is expected to grow in the future due to the increasing adoption of advanced treatment procedures and favorable government initiatives. Varicose veins are large, swollen veins that often appear on the legs and feet. They happen when the valves in the veins do not work properly, so the blood does not flow effectively. Furthermore, an increasing number of ABVLM-certified physicians will boost the demand for minimally invasive laser therapy to treat varicose veins.

The market study is being classified and major geographies with country level break-up.

Medtronic plc (Ireland), AngioDynamics, Inc. (United States), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (United Kingdom), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (United States) and Quanta System S.p.A. (Italy) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Sciton, Inc. (United States), Fotona d.o.o. (Slovenia), BTG plc (United Kingdom) and Merz Aesthetics (United States).

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Global Players will contribute to the maximum growth of Global Varicose veins treatment market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Varicose veins treatment market by Type, Application and Region.

On the basis of geography, the market of Varicose veins treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rising Incidence and Prevalence of Varicose Veins Worldwide
  • Increasing Geriatric Population

Market Trend
  • Technological Advancement in the Varicose Veins Treatment Device

Restraints
  • High Cost of Treatment

Opportunities
  • Increasing Number of ABVLM-certified Physicians
  • Availability of Advanced Healthcare Infrastructure in Developing Countries

Challenges
  • Risk Factors associated with the Treatment Devices


Market Leaders and some development strategies
In Aug 2019, Boston Scientific Corp. announced the completion of its acquisition of BTG plc. pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals.
In June 2020, Medtronic plc announced the first-ever results from the ABRE clinical study assessing the safety and effectiveness of the investigational Abre™ venous self-expanding stent system in subjects with iliofemoral venous outflow obstruction. The study met the primary safety and effectiveness endpoints.
In February 2015, the Food and Drug Administration (FDA) reviewed data for the premarket approval of the VenaSeal system. The FDA approval for the VenaSeal system included from the analysis of results from three clinical studies. Medtronic announced that new CPT codes may aid in getting positive coverage for its VenaSeal closure device from the public and private insurers in the United States in November 2017.

Key Target Audience
Varicose vein treatment Provider, Treatment Product Manufacturers, Vendors, and Distributors, Research Institutes, Government Organizations, Venture capitalists and other government funding organizations, Research and Consulting Firms, Healthcare Industry, Pharmaceutical Companies and Biotechnology Companies

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Treatment
  • Surgery
  • Ligation and Stripping
  • Sclerotherapy
  • Radiofrequency Ablation
  • Endovenous Laser Treatment
  • Transilluminated Powered Phlebectomy

By Disease
  • Greater Saphenous Varicose Vein
  • Small Saphenous Varicose Vein
  • Others

By Product
  • Laser & RF Ablation
  • Venous Closure
  • Surgical

By Diagnosis
  • Doppler Test
  • Color Duplex Ultrasound Scan

By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Incidence and Prevalence of Varicose Veins Worldwide
      • 3.2.2. Increasing Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Risk Factors associated with the Treatment Devices
    • 3.4. Market Trends
      • 3.4.1. Technological Advancement in the Varicose Veins Treatment Device
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Varicose veins treatment, by Treatment, Disease, Product, Diagnosis, End User and Region (value) (2014-2019)
    • 5.1. Introduction
  • 6. Varicose veins treatment: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Medtronic plc (Ireland)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. AngioDynamics, Inc. (United States)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Biolitec AG (Austria)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Syneron Medical Ltd. (Israel)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Lumenis Ltd. (Israel)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Dornier MedTech GmbH (Germany)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Energist Group (United Kingdom)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. Eufoton s.r.l. (Italy)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. Vascular Solutions, Inc. (United States)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
      • 6.1.10. Quanta System S.p.A. (Italy)
        • 6.1.10.1. Business Overview
        • 6.1.10.2. Products/Services Offerings
        • 6.1.10.3. Financial Analysis
        • 6.1.10.4. SWOT Analysis
  • 7. Global Varicose veins treatment Sale, by Treatment, Disease, Product, Diagnosis, End User and Region (value) (2020-2025)
    • 7.1. Introduction
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Company Basic Information, Sales Area and Its Competitors
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Company Basic Information, Sales Area and Its Competitors
  • Table 10. Company Basic Information, Sales Area and Its Competitors
  • Table 11. Research Programs/Design for This Report
  • Table 12. Key Data Information from Secondary Sources
  • Table 13. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 5. Medtronic plc (Ireland) Revenue: by Geography 2019
  • Figure 6. AngioDynamics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 7. AngioDynamics, Inc. (United States) Revenue: by Geography 2019
  • Figure 8. Biolitec AG (Austria) Revenue, Net Income and Gross profit
  • Figure 9. Biolitec AG (Austria) Revenue: by Geography 2019
  • Figure 10. Syneron Medical Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 11. Syneron Medical Ltd. (Israel) Revenue: by Geography 2019
  • Figure 12. Lumenis Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 13. Lumenis Ltd. (Israel) Revenue: by Geography 2019
  • Figure 14. Dornier MedTech GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 15. Dornier MedTech GmbH (Germany) Revenue: by Geography 2019
  • Figure 16. Energist Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 17. Energist Group (United Kingdom) Revenue: by Geography 2019
  • Figure 18. Eufoton s.r.l. (Italy) Revenue, Net Income and Gross profit
  • Figure 19. Eufoton s.r.l. (Italy) Revenue: by Geography 2019
  • Figure 20. Vascular Solutions, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Vascular Solutions, Inc. (United States) Revenue: by Geography 2019
  • Figure 22. Quanta System S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 23. Quanta System S.p.A. (Italy) Revenue: by Geography 2019
Some of the key companies/manufacturers profiled in the report
  • Medtronic plc (Ireland)
  • AngioDynamics, Inc. (United States)
  • biolitec AG (Austria)
  • Syneron Medical Ltd. (Israel)
  • Lumenis Ltd. (Israel)
  • Dornier MedTech GmbH (Germany)
  • Energist Group (United Kingdom)
  • Eufoton s.r.l. (Italy)
  • Vascular Solutions, Inc. (United States)
  • Quanta System S.p.A. (Italy)
Additional players considered in the study are as follows:
Sciton, Inc. (United States) , Fotona d.o.o. (Slovenia) , BTG plc (United Kingdom) , Merz Aesthetics (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation